Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025
    • Class of 2024

Search form

Home

News You Need to Know Today
New details prompt more questions about fatal MRI accident | MRI biomarker predicts cognitive impairment post-stroke | More
Friday, August 1, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New details surrounding fatal Long Island MRI accident prompt more questions

New information indicates Nassau Open MRI has closed circuit video cameras throughout its facility, including in the control room of the MRI trailer attached to the building where the accident took place. 

READ MORE >
MRI safety zone warning sign at entrance into an MRI imaging room at Northwestern Central DuPage Hospital.
Share on Twitter Share on Facebook Share on Linkedin

New details surrounding fatal Long Island MRI accident prompt more questions

Share on Twitter Share on Facebook Share on Linkedin
MRI safety zone warning sign at entrance into an MRI imaging room at Northwestern Central DuPage Hospital.
New information indicates Nassau Open MRI has closed circuit video cameras throughout its facility, including in the control room of the MRI trailer attached to the building where the accident took place. 
READ MORE >

MRI biomarker could identify patients at risk of cognitive decline post-stroke

A new study’s findings highlight the potential for imaging biomarkers to help guide post-stroke care decisions in the future. 

READ MORE >
MRI biomarkers predict cognitive impairment post-stroke
Share on Twitter Share on Facebook Share on Linkedin

MRI biomarker could identify patients at risk of cognitive decline post-stroke

Share on Twitter Share on Facebook Share on Linkedin
MRI biomarkers predict cognitive impairment post-stroke
A new study’s findings highlight the potential for imaging biomarkers to help guide post-stroke care decisions in the future. 
READ MORE >

ARRT is rolling out a new imaging assistant credential for MRI settings

The American Registry Of Radiologic Technologists says the new offering addresses growing demand for magnetic resonance imaging.

READ MORE >
technologist MRI rad tech radiologic radiology
Share on Twitter Share on Facebook Share on Linkedin

ARRT is rolling out a new imaging assistant credential for MRI settings

Share on Twitter Share on Facebook Share on Linkedin
technologist MRI rad tech radiologic radiology
The American Registry Of Radiologic Technologists says the new offering addresses growing demand for magnetic resonance imaging.
READ MORE >

In Case You Missed It

'Revolutionary' AI risk assessment tool earns FDA's Breakthrough Device designation

The technology is said to be twice as accurate at predicting five-year cancer risk compared to current risk assessment methods.

READ MORE >
WashU AI device earns FDA's Breakthrough Device designation.
Share on Twitter Share on Facebook Share on Linkedin

'Revolutionary' AI risk assessment tool earns FDA's Breakthrough Device designation

Share on Twitter Share on Facebook Share on Linkedin
WashU AI device earns FDA's Breakthrough Device designation.
The technology is said to be twice as accurate at predicting five-year cancer risk compared to current risk assessment methods.
READ MORE >

Novel shielding device gives patients 80% better protection from radiation during mammograms

Experts are hopeful their device can address some of the shortcomings of currently used shielding methods. 

READ MORE >
Novel shielding device provides more radiation protection during mammograms.
Share on Twitter Share on Facebook Share on Linkedin

Novel shielding device gives patients 80% better protection from radiation during mammograms

Share on Twitter Share on Facebook Share on Linkedin
Novel shielding device provides more radiation protection during mammograms.
Experts are hopeful their device can address some of the shortcomings of currently used shielding methods. 
READ MORE >

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care

The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

READ MORE >
ovaries ovarian cancer
Share on Twitter Share on Facebook Share on Linkedin

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care

Share on Twitter Share on Facebook Share on Linkedin
ovaries ovarian cancer
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.
READ MORE >

In Other News

AI can be health equity’s best friend—or one of its worst frenemies

AI can hurt or help the cause of advancing equality of resources, services and outcomes in healthcare. If it’s to do more helping than hurting, the technology must permeate primary care—and do so with certain goals and guidelines. 

READ MORE >
medical students artificial intelligence AI
Share on Twitter Share on Facebook Share on Linkedin

AI can be health equity’s best friend—or one of its worst frenemies

Share on Twitter Share on Facebook Share on Linkedin
medical students artificial intelligence AI
AI can hurt or help the cause of advancing equality of resources, services and outcomes in healthcare. If it’s to do more helping than hurting, the technology must permeate primary care—and do so with certain goals and guidelines. 
READ MORE >

Technologists shouldn’t be alone when administering contrast for remote imaging scans, radiology groups say

One imaging policy expert called this stance from ACR and ASRT a “devastating blow” to physician offices and independent diagnostic testing facilities who use virtual supervision for Medicare patients. 

READ MORE >
Patient undergoes a CT scan with IV contrast at Wellstar Kennestone Hospital. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Technologists shouldn’t be alone when administering contrast for remote imaging scans, radiology groups say

Share on Twitter Share on Facebook Share on Linkedin
Patient undergoes a CT scan with IV contrast at Wellstar Kennestone Hospital. Photo by Dave Fornell
One imaging policy expert called this stance from ACR and ASRT a “devastating blow” to physician offices and independent diagnostic testing facilities who use virtual supervision for Medicare patients. 
READ MORE >

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.

READ MORE >
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
Share on Twitter Share on Facebook Share on Linkedin

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Share on Twitter Share on Facebook Share on Linkedin
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.
READ MORE >

Battle lines drawn as Kennedy mulls firing the USPSTF

By now the pleas for Kennedy to reconsider, initially sporadic, have gathered into a steady drumbeat.  

READ MORE >
HHS Secretary Robert F. Kennedy Jr.
Share on Twitter Share on Facebook Share on Linkedin

Battle lines drawn as Kennedy mulls firing the USPSTF

Share on Twitter Share on Facebook Share on Linkedin
HHS Secretary Robert F. Kennedy Jr.
By now the pleas for Kennedy to reconsider, initially sporadic, have gathered into a steady drumbeat.  
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

How departments are reducing wait times | Program increases exposure to radiology careers | Gaps in radiation safety knowledge
A warning about BI-RADS | 3-step buyer's guide for radiology AI | IR procedure reduces steroid reliance for KOA | Rad turnover
Radiologists worry of ripple effect after false claims | AI matches rads at prostate cancer detection | Rad Partners scores win
GE HealthCare acquiring radiopharma firm | RP seeks to expand teleradiology services | Telix and ITM merge in $1.65B deal | More
Siemens Healthineers ends general ultrasound sales | More liver cancer patients turning to IR treatments | Anxiety on MRI
Imaging systems recalled after 4 deaths | Radiology trainees balk at strict in-person work models | Bayer sells Blackford
Best of the Week: 8 years in jail for $37M radiology scam | Rad Partners seeks $485M loan | IR procedure relieves carpal tunnel
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup